Ask AI

Capsule Summary Slidesets

Share

Program Content

Activities

  • IO/Mini-HCVD ± Blina in ALL
    Phase II Study: Inotuzumab Ozogamicin + Low-Intensity Chemo ± Blinatumomab in Newly Diagnosed Older Patients With Ph- ALL
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AbbVie

AstraZeneca

Celgene

Dova Pharmaceuticals

Gilead Text

Incyte

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Seagen

Takeda Oncology